SCHEMBL27012178

SCHEMBL27012178

Clc1ccc(-c2ccc(-c3ccc(-c4ccccc4)cc3)cc2-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
KDM4E B2RXH2 3/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
DNM1 Q05193 2/20 0.41
MAP4K4 O95819 1/20 0.41
ALDH1A1 P00352 3/20 0.38
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
IDO2 Q6ZQW0 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
MAPK14 Q16539 1/20 0.38
NPC1 O15118 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
MDM2 Q00987 1/20 0.37
HSD17B10 Q99714 1/20 0.36
CNR1 P21554 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29104468 0.93 KDM4E (0.40) CYP1A2KDM4EATML3MBTL1DNM1
SCHEMBL29892286 0.93 KDM4E (0.40) CYP1A2KDM4EATML3MBTL1DNM1
SCHEMBL29892768 0.93 KDM4E (0.40) CYP1A2KDM4EATML3MBTL1DNM1
SCHEMBL21165618 0.92 ATM (0.50) KDM4EATML3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL24948921 0.91 DNM1 (0.39) CYP1A2KDM4EATML3MBTL1DNM1
SCHEMBL24948911 0.90 IDO1 (0.46) CYP1A2KDM4EATML3MBTL1ALDH1A1
SCHEMBL27012163 0.89 CYP1A2 (0.46) CYP1A2KDM4EATML3MBTL1DNM1
SCHEMBL30257606 0.89 CYP1A2 (0.40) CYP1A2KDM4EDNM1MAP4K4ALDH1A1
SCHEMBL17714934 0.88 DNM1 (0.46) CYP1A2KDM4EATML3MBTL1DNM1
SCHEMBL30256945 0.88 DNM1 (0.46) CYP1A2KDM4EATML3MBTL1DNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-01-18 US disclosed
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018104-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 CYP1A2 1918/4885KDM4E 436/4885ATM 2358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.